Associate Professor, Internal Med Dept Lubbock Genl
TEXAS TECH UNIVERSITY
Maurizio Chiriva-Internati completed his Doctorates in Immunology at the University of Nottingham, UK and Morphological Sciences at the University of Milan, Italy. He completed his Postdoctoral research on tumor immunology and cancer vaccine studies from the University of Arkansas for Medical Sciences. Currently, he is the Director of Basic and Translational Research at the division on Hematology & Oncology at the Texas Tech University Health Sciences Center, School of Medicine, and is a senior editor for the Journal, International Reviews of Immunology. He has published more than 100 papers in peer-reviewed journals and serves as on the Editorial Board of several journals.
antigens as therapeutic and diagnostic tools,novel cancer testis antigens for the development of immunotherapeutic strategies against solid and non-solid tumors,new therapies for multiple myeloma, ovarian and lung cancer, and prostate cancer and melanoma